Toward a Clinical Decision Support System for Monitoring Therapeutic Antituberculosis Medical Drugs in Tanzania (Project TuberXpert): Protocol for an Algorithm' Development and Implementation.

Autor: Thoma Y; School of Engineering and Management Vaud, HES-SO University of Applied Sciences and Arts Western Switzerland, Yverdon-les-Bains, Switzerland., Cathignol AE; School of Engineering and Management Vaud, HES-SO University of Applied Sciences and Arts Western Switzerland, Yverdon-les-Bains, Switzerland.; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Pétermann YJ; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Sariko ML; Kilimanjaro Clinical Research Institute, Moshi, United Republic of Tanzania., Said B; Kibong'oto Infectious Diseases Hospital, Sanya Juu, United Republic of Tanzania.; The Nelson Mandela African Institution of Science and Technology, Arusha, United Republic of Tanzania., Csajka C; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland., Guidi M; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.; Service of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Mpagama SG; Kibong'oto Infectious Diseases Hospital, Sanya Juu, United Republic of Tanzania.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2024 Oct 21; Vol. 13, pp. e58720. Date of Electronic Publication: 2024 Oct 21.

Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates.

Autor: Alrahahleh D; Faculty of Medicine and Health, Sydney Pharmacy School, The University of Sydney, Pharmacy Building (A15), Camperdown, NSW, 2006, Australia.; Westmead Hospital, Westmead, NSW, Australia.; The University Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Westmead, NSW, Australia., Thoma Y; School of Engineering and Management Vaud, HES-SO University of Applied Sciences and Arts Western Switzerland, 1400, Yverdon-les-Bains, Switzerland., Van Daele R; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000, Leuven, Belgium.; Pharmacy Department, University Hospitals Leuven, 3000, Leuven, Belgium., Nguyen T; Faculty of Medicine and Health, Sydney Pharmacy School, The University of Sydney, Pharmacy Building (A15), Camperdown, NSW, 2006, Australia.; Westmead Hospital, Westmead, NSW, Australia.; The University Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Westmead, NSW, Australia., Halena S; Department of Pharmacy, Westmead Hospital, NSW, Westmead, Australia., Luig M; Department of Neonatology, Westmead Hospital, Westmead, NSW, Australia., Stocker S; Faculty of Medicine and Health, Sydney Pharmacy School, The University of Sydney, Pharmacy Building (A15), Camperdown, NSW, 2006, Australia.; Westmead Hospital, Westmead, NSW, Australia.; The University Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Westmead, NSW, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney, Sydney, Australia., Kim HY; Faculty of Medicine and Health, Sydney Pharmacy School, The University of Sydney, Pharmacy Building (A15), Camperdown, NSW, 2006, Australia.; The University Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Westmead, NSW, Australia.; Department of Pharmacy, Westmead Hospital, NSW, Westmead, Australia., Alffenaar JW; Faculty of Medicine and Health, Sydney Pharmacy School, The University of Sydney, Pharmacy Building (A15), Camperdown, NSW, 2006, Australia. johannes.alffenaar@sydney.edu.au.; Westmead Hospital, Westmead, NSW, Australia. johannes.alffenaar@sydney.edu.au.; The University Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Westmead, NSW, Australia. johannes.alffenaar@sydney.edu.au.

Publikováno v: Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Mar; Vol. 63 (3), pp. 367-380. Date of Electronic Publication: 2024 Feb 28.

AUC-based monitoring and model-informed precision dosing of vancomycin in critically ill patients: why and how?

Autor: Goutelle S; Hospices Civils de Lyon, Groupement Hospitalier Nord, Service de Pharmacie, Lyon, France; Université of Lyon, Université Claude Bernard Lyon 1, UMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive, Villeurbanne, France; Université of Lyon, Université Claude Bernard Lyon 1, Facultés de Médecine et de Pharmacie de Lyon, Lyon, France. Electronic address: sylvain.goutelle@chu-lyon.fr., Wallet F; Hospices Civils de Lyon, GH Sud, Services d'Anesthésie-réanimation Médecine Intensive, Lyon, France; Université of Lyon, Université Claude Bernard Lyon 1, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Lyon, France., Thoma Y; School of Management and Engineering Vaud (HEIG-VD), HES-SO University of Applied Sciences and Arts Western Switzerland, Yverdon-les-Bains, Switzerland., Peclard JR; School of Management and Engineering Vaud (HEIG-VD), HES-SO University of Applied Sciences and Arts Western Switzerland, Yverdon-les-Bains, Switzerland., Bourguignon L; Hospices Civils de Lyon, Groupement Hospitalier Nord, Service de Pharmacie, Lyon, France; Université of Lyon, Université Claude Bernard Lyon 1, UMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive, Villeurbanne, France; Université of Lyon, Université Claude Bernard Lyon 1, Facultés de Médecine et de Pharmacie de Lyon, Lyon, France., Cohen S; Hospices Civils de Lyon, GH Sud, Laboratoire de Pharmaco-toxicologie, France., Kipnis E; Université of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Roberts J; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia; Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Australia; Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France., Allaouchiche B; Université of Lyon, Université Claude Bernard Lyon 1, Facultés de Médecine et de Pharmacie de Lyon, Lyon, France; Hospices Civils de Lyon, GH Sud, Services d'Anesthésie-réanimation Médecine Intensive, Lyon, France; Lyon University, VetAgro Sup, Lyon Veterinary Campus, UPSP 2016. A101, Pulmonary and Cardiovascular Agression in Sepsis, Marcy l'Étoile, France., Friggeri A; Université of Lyon, Université Claude Bernard Lyon 1, Facultés de Médecine et de Pharmacie de Lyon, Lyon, France; Hospices Civils de Lyon, GH Sud, Services d'Anesthésie-réanimation Médecine Intensive, Lyon, France; Université of Lyon, Université Claude Bernard Lyon 1, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Lyon, France.

Publikováno v: Anaesthesia, critical care & pain medicine [Anaesth Crit Care Pain Med] 2023 Dec; Vol. 42 (6), pp. 101286. Date of Electronic Publication: 2023 Jul 28.

Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective.

Autor: Briki M; Service and Laboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.; Bio/CMOS Interfaces Laboratory, École Polytechnique Fédérale de Lausanne-EPFL, 2002 Neuchâtel, Switzerland., André P; Service and Laboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland., Thoma Y; School of Engineering and Management Vaud, HES-SO University of Applied Sciences and Arts Western Switzerland, 1401 Yverdon-les-Bains, Switzerland., Widmer N; Service and Laboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.; Pharmacy of the Eastern Vaud Hospitals, 1847 Rennaz, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, 1206 Geneva, Switzerland., Wagner AD; Service of Medical Oncology, Department of Oncology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland., Decosterd LA; Service and Laboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland., Buclin T; Service and Laboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland., Guidi M; Service and Laboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, 1206 Geneva, Switzerland.; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland., Carrara S; Bio/CMOS Interfaces Laboratory, École Polytechnique Fédérale de Lausanne-EPFL, 2002 Neuchâtel, Switzerland.

Publikováno v: Pharmaceutics [Pharmaceutics] 2023 Apr 19; Vol. 15 (4). Date of Electronic Publication: 2023 Apr 19.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.